Mice transgenic for human CD4 and CCR5 are susceptible to HIV infection - Wikidata - wikimedia - TriplyDB

Mice transgenic for human CD4 and CCR5 are susceptible to HIV infection

Mice transgenic for human CD4 and CCR5 are susceptible to HIV infection

http://www.wikidata.org/entity/Q36828663

about

Mice transgenic for equine cyclin T1 and ELR1 are susceptible to equine infectious anemia virus infection TRIM5α and Species Tropism of HIV/SIV HIV type-1 infection of the cotton rat (Sigmodon fulviventer and S. hispidus)Studies of retroviral infection in humanized mice Humanized mice: novel model for studying mechanisms of human immune-based therapies Animal models for HIV/AIDS research Multiple blocks to human immunodeficiency virus type 1 replication in rodent cells Short communication: Methamphetamine treatment increases in vitro and in vivo HIV replication.Dendritic cells route human immunodeficiency virus to lymph nodes after vaginal or intravenous administration to mice Rabbit cells expressing human CD4 and human CCR5 are highly permissive for human immunodeficiency virus type 1 infection A block to human immunodeficiency virus type 1 assembly in murine cells.Mouse-human heterokaryons support efficient human immunodeficiency virus type 1 assembly.A mouse model for study of systemic HIV-1 infection, antiviral immune responses, and neuroinvasiveness.Efficient assembly of an HIV-1/MLV Gag-chimeric virus in murine cells Highly active antiretroviral therapy potently suppresses HIV infection in humanized Rag2-/-gammac-/- mice High natural permissivity of primary rabbit cells for HIV-1, with a virion infectivity defect in macrophages as the final replication barrier.Mice transgenic for a human porcine endogenous retrovirus receptor are susceptible to productive viral infection.Mice transgenic for CD4-specific human CD4, CCR5 and cyclin T1 expression: a new model for investigating HIV-1 transmission and treatment efficacy.Induction of primary virus-cross-reactive human immunodeficiency virus type 1-neutralizing antibodies in small animals by using an alphavirus-derived in vivo expression system An alteration of human immunodeficiency virus gp41 leads to reduced CCR5 dependence and CD4 independence.Susceptibility of mink (Mustera vision)-derived cells to replication by human immunodeficiency virus type 1 Postentry restriction of Mason-Pfizer monkey virus in mouse cells Disseminated and sustained HIV infection in CD34+ cord blood cell-transplanted Rag2-/-gamma c-/- mice Nuclear import of the preintegration complex is blocked upon infection by human immunodeficiency virus type 1 in mouse cells.Use of a novel chimeric mouse model with a functionally active human immune system to study human immunodeficiency virus type 1 infection Primary T-cells from human CD4/CCR5-transgenic rats support all early steps of HIV-1 replication including integration, but display impaired viral gene expression.A mouse model for HIV-1 entry Human CRM1 augments production of infectious human and feline immunodeficiency viruses from murine cells.Progress toward a human CD4/CCR5 transgenic rat model for de novo infection by human immunodeficiency virus type 1.Blockade of HIV-1 infection of New World monkey cells occurs primarily at the stage of virus entry.Relief of preintegration inhibition and characterization of additional blocks for HIV replication in primary mouse T cells.Increased in vivo activation of microglia and astrocytes in the brains of mice transgenic for an infectious R5 human immunodeficiency virus type 1 provirus and for CD4-specific expression of human cyclin T1 in response to stimulation by lipopolysacc Human immunodeficiency virus type 1 infection increases the in vivo capacity of peripheral monocytes to cross the blood-brain barrier into the brain and the in vivo sensitivity of the blood-brain barrier to disruption by lipopolysaccharide.Mouse T-cells restrict replication of human immunodeficiency virus at the level of integration.Capsid-dependent and -independent postentry restriction of primate lentivirus tropism in rodent cells Antibody and antiretroviral preexposure prophylaxis prevent cervicovaginal HIV-1 infection in a transgenic mouse model.Murine models for HIV vaccination and challenge.Replication of equine infectious anemia virus in engineered mouse NIH 3T3 cells.Expression of Human CD4 and chemokine receptors in cotton rat cells confers permissiveness for productive HIV infection.Induction of robust cellular and humoral virus-specific adaptive immune responses in human immunodeficiency virus-infected humanized BLT mice.

P2860

Q21146658-E8DA2B84-B0A7-401D-A075-05F078FAE973 Q24304062-A5D97137-2874-495D-B574-CE71046774E3 Q24651142-060BE673-B521-4910-B087-5E954B1BC608 Q26849806-3B8BE368-8378-4A3D-8F2F-35C27F20A030 Q26996648-00B675F0-06E6-4F6C-B260-AF93CA6EDEE7 Q30423656-E9F6B8F7-0A8C-4C14-9012-2C239B321836 Q33603453-2BEFD6D0-A2B2-412D-9FF7-BE57CAFC3AD4 Q33686683-B3C62E66-AAD1-4FF6-9E53-7701D350EECA Q33784661-56C2558D-330C-4A4D-AFE6-F416991C0E4F Q33785137-AAAF1B44-EDE8-48CC-9178-1EA5A2381D67 Q33802821-1FB514DE-C275-482E-89A7-E8C900455B6A Q33837992-7379B0D6-1CBB-4AB5-955B-A1ECF82E59C3 Q33928648-8DC41822-9A53-41B1-8EE8-2CD0FED92C2C Q33953076-ED063C48-94E8-482C-87E2-B9534ED7B832 Q34100221-E8054061-8E7F-4287-8120-C0225AFB773F Q34291018-CE2F2A83-68F2-480E-B563-41C34CD3347A Q34545753-214264CA-FF23-4DE2-B50B-2177B1703B4E Q34730602-39E172F6-0420-4DAC-A061-A2FD12212D19 Q34754733-F2E3197C-DFA6-4635-BBB8-5D568BC4EDDE Q34763384-43FA1C39-00C8-4422-B918-BA13C9764E91 Q34976301-02AC143F-F5D8-42FE-8078-B3897F9494A6 Q35076669-56C001F1-032B-4F88-90DA-EEA1E05980A5 Q35127565-40928DBC-B0B7-4F5D-9D07-6C7C6DD1A39A Q35635000-F1F2430F-3C90-4EF2-AC81-AF35F547B263 Q35783479-4DC387C4-A70A-4552-BA41-DDFC0AB2C2E3 Q35980829-A0ED0137-ACD8-40D1-AEBE-F5E46742E143 Q36300767-C92454A1-2B18-4FD8-92E2-645160967136 Q36363829-0A86119C-49D0-48F7-AF7B-A4F691FAA761 Q36370241-B5172D29-2E26-44AB-88BF-2C3C4513A9F7 Q36376601-8593CCA6-0170-4186-B47B-09A0085D1C44 Q36571363-2071827A-B191-4031-8289-9711C8B14359 Q36673268-960FEAEA-A6E4-4C3A-A671-BE01741C42D0 Q36804543-88350157-6583-46CA-9C3A-D1DE2D1DFA93 Q36916993-3DC01E4E-8FA2-4CDE-9A7D-35E964AE68B3 Q36943400-3348DA68-29F4-410C-B426-456B2DF14BA2 Q37036786-2E6798F3-F784-4B02-BECB-FD11219FE45D Q37077665-7B1FC537-3BB1-4DC5-96BC-281A80A6AC1A Q37099750-9AFADC5C-7720-48FF-B87A-3E11496CD224 Q37209394-5C8FD038-3BEC-4AFD-A0D7-2B338493209A Q37247943-413CCA77-675E-4A7B-92B7-34885ED588FE

P2860

Mice transgenic for human CD4 and CCR5 are susceptible to HIV infection

http://www.wikidata.org/entity/Q36828663

description

1997 nî lūn-bûn

@nan

1997年の論文

@ja

1997年論文

@yue

1997年論文

@zh-hant

1997年論文

@zh-hk

1997年論文

@zh-mo

1997年論文

@zh-tw

1997年论文

@wuu

1997年论文

@zh

1997年论文

@zh-cn

name

Mice transgenic for human CD4 and CCR5 are susceptible to HIV infection

@en

type

label

Mice transgenic for human CD4 and CCR5 are susceptible to HIV infection

@en

prefLabel

Mice transgenic for human CD4 and CCR5 are susceptible to HIV infection

@en

P1433

Q36828663-FBD24FEE-C859-4DE1-9385-E93742B9B50E

P1476

Q36828663-FABB3E82-9C8D-48F9-BA82-9A292F708406

P2093

Q36828663-0BD31B0A-1E78-466E-87A3-A52C5915150E

Q36828663-1F027D09-0F35-49AC-BA99-1456B4D57480

Q36828663-53E891D3-598A-4279-BBF2-504512976E46

Q36828663-5663AC20-DE45-49FA-BED8-C7BC6FF75EB7

Q36828663-61AA3753-00AC-403E-B4B9-2C431B0EDD2F

Q36828663-A743D88E-D9A8-4FBC-A101-8121200262DB

P2860

Q36828663-005E0150-44EB-4FF6-9490-67C995A14D62

Q36828663-0181862A-D2FF-4A9B-9BEA-9C33A3A460AA

Q36828663-1FCF3B8C-2BD2-4313-944E-DDAB86D32DAA

Q36828663-20554102-AF9D-4E95-9857-4AFA9A9EDFB2

Q36828663-21D2A10C-77CF-49EA-96FB-B65F4578DEE6

Q36828663-221A9D5F-1012-4A69-A749-43C1BC6C0A31

Q36828663-2266E5F8-9335-4861-880D-B0D4B4435BF4

Q36828663-247CA2A3-B04A-469B-A556-A383370F438A

Q36828663-2D46A6E3-AB7B-4A47-A00D-5751D79490F5

Q36828663-3C7A9747-A570-49AC-A460-048326FB1FEB

P304

Q36828663-4D0F0EBD-890D-484E-9053-DC4CC76BA010

P31

Q36828663-A8239294-97F5-4299-A64B-629F2B8139C9

P356

Q36828663-C7A7B5DF-CD25-4F07-9C26-D6CB818DFE26

P407

Q36828663-C832C29B-52A7-4335-9713-1B280061C5CD

P433

Q36828663-56A35143-649B-479B-9437-3933D219B17B

P478

Q36828663-FE3BEFA5-6871-439A-BB2C-AEFC488750FE

P50

Q36828663-4BD5BB10-6B59-4776-ADB5-8F842F0C292F

P577

Q36828663-46F07E9D-CD94-47A4-8321-1E30EAAE16DA

P5875

Q36828663-4A367A7D-DB80-4CAB-9FB3-57BBD681B276

P698

Q36828663-F225C952-46D5-4797-90C8-51D53E8882D4

P932

Q36828663-4A4863FC-180A-4C47-BDC0-030F2B3550B8

P356

PNAS.94.26.14637

P1433

Proceedings of the National Academy of Sciences of the United States of America

P1476

Mice transgenic for human CD4 and CCR5 are susceptible to HIV infection

@en

P2093

C Raker

http://www.w3.org/2001/XMLSchema#string

H Goldstein

http://www.w3.org/2001/XMLSchema#string

J Browning

http://www.w3.org/2001/XMLSchema#string

J W Horner

http://www.w3.org/2001/XMLSchema#string

R A DePinho

http://www.w3.org/2001/XMLSchema#string

S Yurasov

http://www.w3.org/2001/XMLSchema#string

P2860

HIV-1 Entry Cofactor: Functional cDNA Cloning of a Seven-Transmembrane, G Protein-Coupled Receptor

Identification of a major co-receptor for primary isolates of HIV-1

Expression cloning of new receptors used by simian and human immunodeficiency viruses

STRL33, A novel chemokine receptor-like protein, functions as a fusion cofactor for both macrophage-tropic and T cell line-tropic HIV-1

A dual-tropic primary HIV-1 isolate that uses fusin and the beta-chemokine receptors CKR-5, CKR-3, and CKR-2b as fusion cofactors

The beta-chemokine receptors CCR3 and CCR5 facilitate infection by primary HIV-1 isolates

T-lymphocyte T4 molecule behaves as the receptor for human retrovirus LAV

HIV-1 dynamics in vivo: virion clearance rate, infected cell life-span, and viral generation time

Resistance to HIV-1 infection in caucasian individuals bearing mutant alleles of the CCR-5 chemokine receptor gene

Homozygous defect in HIV-1 coreceptor accounts for resistance of some multiply-exposed individuals to HIV-1 infection

P304

14637-14641

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1073/PNAS.94.26.14637

http://www.w3.org/2001/XMLSchema#string

P407

P433

26

http://www.w3.org/2001/XMLSchema#string

P478

94

http://www.w3.org/2001/XMLSchema#string

P50

M Pettoello-Mantovani

P577

1997-12-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

13823899

http://www.w3.org/2001/XMLSchema#string

P698

9405665

http://www.w3.org/2001/XMLSchema#string

P932

25078

http://www.w3.org/2001/XMLSchema#string